Administrative Core
Administrative Core
批准号:
7683382
负责人:
JOSEPH H ANTIN
金额:
$5.76万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2014-03-31
中文摘要
行政核心,即核心A,将为项目提供行政和财政管理,并
P01的核心。目标是组织管理项目和核心的工作人员与
项目负责人、核心负责人和机构工作人员,组织和主持P01的月度会议
P01参与者和科学咨询委员会(SAB)的参与者和年会,准备
与P01活动有关的必要文件,包括P01调查员会议和SAB的报告;
并为官方机构编写进度报告,促进个别项目之间的互动
在项目和核心之间建立联系,并定期监测个别项目的进展情况,以
保持对项目和项目的适当财政监督,并编制必要的官方财政报告
机构,并确保遵守有关人体试验的适当法规
研究对象包括性别和参与程度较低的脊椎动物.
相关性(请参阅说明):
核心A是组织和协调项目和其他核心所必需的。
英文摘要
The administrative core, Core A, will provide administrative and fiscal management for the projects and
cores of the P01. The goals are to organize staff administer the projects and cores in conjunction with
project leaders, core directors and institutional staff, organize and conduct monthly meetings of P01
participants and annual meetings of P01 participants and the Scientific Advisory Board (SAB), prepare the
necessary documents related to P01 activities, including reports of P01 investigator meetings and the SAB,
and prepare progress reports for official agencies, facilitate interaction between individual projects and
between projects and cores and monitor the progress of the individual projects on a regular basis, to
maintain appropriate fiscal oversight of the projects and cords and prepare necessary fiscal reports of official
agencies, and to assure compliance with appropriate regulations regarding experimentation with human
subjects including gender and minor participation an vertebrate animals.
RELEVANCE (See instructions):
Core A is necessary to organize and coordinate the projects and other cores.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanisms of GVHD
-
批准号:8257940
-
项目类别:
-
资助金额:$186.73万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:7804574
-
项目类别:
-
资助金额:$191.63万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:8468127
-
项目类别:
-
资助金额:$175.53万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:8066713
-
项目类别:
-
资助金额:$186.73万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:7628771
-
项目类别:
-
资助金额:$195.33万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Novel Approaches to Graft-versus-Host Disease Prevention
-
批准号:7683379
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2009
-
负责人:JOSEPH H ANTIN
-
依托单位:
Novel Approaches to GHVD Prevention
-
批准号:7393102
-
项目类别:
-
资助金额:$48.3万
-
财政年份:2007
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:7226014
-
项目类别:
-
资助金额:$202.56万
-
财政年份:2003
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:6883249
-
项目类别:
-
资助金额:$203.42万
-
财政年份:2003
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:7045976
-
项目类别:
-
资助金额:$203.55万
-
财政年份:2003
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:6602946
-
项目类别:
-
资助金额:$201.24万
-
财政年份:2003
-
负责人:JOSEPH H ANTIN
-
依托单位:
Mechanisms of GVHD
-
批准号:6732698
-
项目类别:
-
资助金额:$205.68万
-
财政年份:2003
-
负责人:JOSEPH H ANTIN
-
依托单位:
A Randomized Trial of Tac/MTX/bortezomib vs Tac/MTXplacebo in Allogeneic HSCT
-
批准号:8174282
-
项目类别:
-
资助金额:$17.33万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Random Trial of CD8 T-Cell Depletion in PBSC Transplantation
-
批准号:7891393
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Random Trial of CD8 T-Cell Depletion in PBSC Transplantation
-
批准号:7124928
-
项目类别:
-
资助金额:$15.5万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
A randomized phase 2 trial to compare standard-of-care steroids vs. steroids plus low-dose IL-2 vs. steroids plus low-dose IL-2 and rituximab for upfront treatment of chronic GVHD
-
批准号:10430183
-
项目类别:
-
资助金额:$20.32万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Randomized Trial of CD8 T-Cell Depletion in PBSC Transp*
-
批准号:6439077
-
项目类别:
-
资助金额:$40.49万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Randomized Trial of CD8 T-Cell Depletion in PBSC Transp*
-
批准号:6527910
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Randomized Trial of CD8 T-Cell Depletion in PBSC Transp*
-
批准号:6794602
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
Random Trial of CD8 T-Cell Depletion in PBSC Transplantation
-
批准号:7290402
-
项目类别:
-
资助金额:$1.12万
-
财政年份:2001
-
负责人:JOSEPH H ANTIN
-
依托单位:
海外基金